Intense basolateral membrane staining indicates HER2 positivity in invasive micropapillary breast carcinoma View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2020-01-23

AUTHORS

Shuling Zhou, Fei Yang, Qianming Bai, Anqi Li, Ming Li, Siyuan Zhong, Hong Lv, Ruohong Shui, Xiaoyu Tu, Rui Bi, Xiaoli Xu, Yufan Cheng, Baohua Yu, Shaoxian Tang, Xiangjie Sun, Xiaoyan Zhou, Wentao Yang

ABSTRACT

Invasive micropapillary carcinoma is characterized by the inside-out growth of tumor clusters and displays incomplete membrane immunostaining of HER2. According to the 2018 American Society of Clinical Oncology and the College of American Pathologists (ASCO/CAP) HER2-testing recommendation, moderate to intense but incomplete staining could be scored as immunohistochemical 2+. Furthermore, the criteria of immunohistochemical 3+ for this staining pattern are not mentioned. One hundred and forty-seven cases of invasive micropapillary carcinoma with moderate-to-intense HER2 immunostaining were enrolled. Invasive micropapillary carcinoma components of all cases were scored as immunohistochemical 2+ based on the 2018 ASCO/CAP recommendation. The invasive micropapillary carcinoma component varied from 10% to 100% (mean, 80%). Invasive micropapillary carcinoma components of all 147 tumors exhibited reversed polarity and incomplete basolateral HER2 membrane staining. One hundred and seventeen of the tumors (80%, 117/147) had moderate staining, and 38 (32%, 38/117) showed HER2 gene amplification by fluorescence in-situ hybridization. HER2 gene was amplified in all the remaining 30 tumors (20%, 30/147) that exhibited intense basolateral membrane staining. Besides, average HER2 signals per cell and ratio of HER2/CEP17 were significantly higher in the intense-staining tumors compared with the moderate-staining tumors (p < 0.0001). Follow-up data were available for 140 patients. None of the patients were died. The follow-up time ranged from 1 month to 99 months (median, 57 months). Thirteen (9%, 13/140) patients exhibited disease progression (recurrence or metastasis). HER2 gene amplification was correlated inversely with estrogen receptor (p = 0.000) and progesterone receptor (p = 0.000) expression, and positively with histological grade (p = 0.003) and disease progression (p = 0.000). Invasive micropapillary carcinoma with intense clear linear basolateral membrane immunostaining indicates HER2 positivity, even if the staining is incomplete. They should be classified as immunohistochemical 3+ rather than immunohistochemical 2+, which would avoid further fluorescence in-situ hybridization-testing procedure and greatly save the related time, labor, and financial costs. Ultimately, ensure all patients with HER2 gene amplification obtain effective targeted therapy in time. More... »

PAGES

1275-1286

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/s41379-020-0461-z

DOI

http://dx.doi.org/10.1038/s41379-020-0461-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1124225350

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/31974492


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Ductal, Breast", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunohistochemistry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptor, ErbB-2", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
          "id": "http://www.grid.ac/institutes/grid.11841.3d", 
          "name": [
            "Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
            "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhou", 
        "givenName": "Shuling", 
        "id": "sg:person.01106150266.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106150266.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
          "id": "http://www.grid.ac/institutes/grid.11841.3d", 
          "name": [
            "Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
            "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yang", 
        "givenName": "Fei", 
        "id": "sg:person.01000326254.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01000326254.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
          "id": "http://www.grid.ac/institutes/grid.11841.3d", 
          "name": [
            "Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
            "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bai", 
        "givenName": "Qianming", 
        "id": "sg:person.01257353151.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257353151.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
          "id": "http://www.grid.ac/institutes/grid.11841.3d", 
          "name": [
            "Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
            "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Li", 
        "givenName": "Anqi", 
        "id": "sg:person.0732213054.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0732213054.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
          "id": "http://www.grid.ac/institutes/grid.11841.3d", 
          "name": [
            "Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
            "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Li", 
        "givenName": "Ming", 
        "id": "sg:person.010367017310.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010367017310.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
          "id": "http://www.grid.ac/institutes/grid.11841.3d", 
          "name": [
            "Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
            "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhong", 
        "givenName": "Siyuan", 
        "id": "sg:person.015065306727.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015065306727.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
          "id": "http://www.grid.ac/institutes/grid.11841.3d", 
          "name": [
            "Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
            "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lv", 
        "givenName": "Hong", 
        "id": "sg:person.016051674573.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016051674573.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
          "id": "http://www.grid.ac/institutes/grid.11841.3d", 
          "name": [
            "Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
            "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shui", 
        "givenName": "Ruohong", 
        "id": "sg:person.0703124734.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703124734.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
          "id": "http://www.grid.ac/institutes/grid.11841.3d", 
          "name": [
            "Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
            "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tu", 
        "givenName": "Xiaoyu", 
        "id": "sg:person.0731707551.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731707551.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
          "id": "http://www.grid.ac/institutes/grid.11841.3d", 
          "name": [
            "Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
            "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bi", 
        "givenName": "Rui", 
        "id": "sg:person.01103220634.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103220634.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
          "id": "http://www.grid.ac/institutes/grid.11841.3d", 
          "name": [
            "Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
            "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Xu", 
        "givenName": "Xiaoli", 
        "id": "sg:person.0652222332.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652222332.79"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
          "id": "http://www.grid.ac/institutes/grid.11841.3d", 
          "name": [
            "Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
            "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cheng", 
        "givenName": "Yufan", 
        "id": "sg:person.01151334034.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01151334034.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
          "id": "http://www.grid.ac/institutes/grid.11841.3d", 
          "name": [
            "Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
            "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yu", 
        "givenName": "Baohua", 
        "id": "sg:person.0635011534.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635011534.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
          "id": "http://www.grid.ac/institutes/grid.11841.3d", 
          "name": [
            "Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
            "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tang", 
        "givenName": "Shaoxian", 
        "id": "sg:person.01047646601.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047646601.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
          "id": "http://www.grid.ac/institutes/grid.11841.3d", 
          "name": [
            "Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
            "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sun", 
        "givenName": "Xiangjie", 
        "id": "sg:person.01253773704.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01253773704.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
          "id": "http://www.grid.ac/institutes/grid.11841.3d", 
          "name": [
            "Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
            "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhou", 
        "givenName": "Xiaoyan", 
        "id": "sg:person.01010610662.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01010610662.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
          "id": "http://www.grid.ac/institutes/grid.11841.3d", 
          "name": [
            "Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong\u2019an Road, 200032, Shanghai, PR China", 
            "Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong\u2019an Road, 200032, Shanghai, PR China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yang", 
        "givenName": "Wentao", 
        "id": "sg:person.01333675634.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333675634.21"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00292-010-1278-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044174834", 
          "https://doi.org/10.1007/s00292-010-1278-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00428-010-0952-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008262506", 
          "https://doi.org/10.1007/s00428-010-0952-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1957.43", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033483945", 
          "https://doi.org/10.1038/bjc.1957.43"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1746-1596-5-50", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078194351", 
          "https://doi.org/10.1186/1746-1596-5-50"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/modpathol.2017.65", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090916693", 
          "https://doi.org/10.1038/modpathol.2017.65"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00432-013-1409-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040283919", 
          "https://doi.org/10.1007/s00432-013-1409-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1097/01.mp.0000052102.90815.82", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043809974", 
          "https://doi.org/10.1097/01.mp.0000052102.90815.82"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-004-8235-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033707946", 
          "https://doi.org/10.1007/s10549-004-8235-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/modpathol.2011.198", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027273989", 
          "https://doi.org/10.1038/modpathol.2011.198"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2020-01-23", 
    "datePublishedReg": "2020-01-23", 
    "description": "Invasive micropapillary carcinoma is characterized by the inside-out growth of tumor clusters and displays incomplete membrane immunostaining of HER2. According to the 2018 American Society of Clinical Oncology and the College of American Pathologists (ASCO/CAP) HER2-testing recommendation, moderate to intense but incomplete staining could be scored as immunohistochemical 2+. Furthermore, the criteria of immunohistochemical 3+ for this staining pattern are not mentioned. One hundred and forty-seven cases of invasive micropapillary carcinoma with moderate-to-intense HER2 immunostaining were enrolled. Invasive micropapillary carcinoma components of all cases were scored as immunohistochemical 2+ based on the 2018 ASCO/CAP recommendation. The invasive micropapillary carcinoma component varied from 10% to 100% (mean, 80%). Invasive micropapillary carcinoma components of all 147 tumors exhibited reversed polarity and incomplete basolateral HER2 membrane staining. One hundred and seventeen of the tumors (80%, 117/147) had moderate staining, and 38 (32%, 38/117) showed HER2 gene amplification by fluorescence in-situ hybridization. HER2 gene was amplified in all the remaining 30 tumors (20%, 30/147) that exhibited intense basolateral membrane staining. Besides, average HER2 signals per cell and ratio of HER2/CEP17 were significantly higher in the intense-staining tumors compared with the moderate-staining tumors (p\u2009<\u20090.0001). Follow-up data were available for 140 patients. None of the patients were died. The follow-up time ranged from 1 month to 99 months (median, 57 months). Thirteen (9%, 13/140) patients exhibited disease progression (recurrence or metastasis). HER2 gene amplification was correlated inversely with estrogen receptor (p\u2009=\u20090.000) and progesterone receptor (p\u2009=\u20090.000) expression, and positively with histological grade (p\u2009=\u20090.003) and disease progression (p\u2009=\u20090.000). Invasive micropapillary carcinoma with intense clear linear basolateral membrane immunostaining indicates HER2 positivity, even if the staining is incomplete. They should be classified as immunohistochemical 3+ rather than immunohistochemical 2+, which would avoid further fluorescence in-situ hybridization-testing procedure and greatly save the related time, labor, and financial costs. Ultimately, ensure all patients with HER2 gene amplification obtain effective targeted therapy in time.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/s41379-020-0461-z", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1098208", 
        "issn": [
          "0893-3952", 
          "1530-0285"
        ], 
        "name": "Modern Pathology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "33"
      }
    ], 
    "keywords": [
      "invasive micropapillary carcinoma component", 
      "micropapillary carcinoma component", 
      "invasive micropapillary carcinoma", 
      "HER2 gene amplification", 
      "micropapillary carcinoma", 
      "carcinoma component", 
      "basolateral membrane staining", 
      "HER2 positivity", 
      "disease progression", 
      "invasive micropapillary breast carcinoma", 
      "micropapillary breast carcinoma", 
      "gene amplification", 
      "ASCO/CAP recommendations", 
      "membrane staining", 
      "HER2/CEP17", 
      "Thirteen patients", 
      "histological grade", 
      "breast carcinoma", 
      "estrogen receptor", 
      "Clinical Oncology", 
      "CAP recommendations", 
      "moderate staining", 
      "HER2 gene", 
      "patients", 
      "carcinoma", 
      "tumors", 
      "incomplete membrane", 
      "tumor clusters", 
      "staining", 
      "American Society", 
      "HER2", 
      "HER2 signals", 
      "progression", 
      "months", 
      "positivity", 
      "situ hybridization", 
      "basolateral membrane", 
      "incomplete staining", 
      "further fluorescence", 
      "financial costs", 
      "therapy", 
      "oncology", 
      "receptors", 
      "related time", 
      "CEP17", 
      "recommendations", 
      "cases", 
      "amplification", 
      "cells", 
      "grade", 
      "membrane", 
      "expression", 
      "time", 
      "criteria", 
      "College", 
      "genes", 
      "procedure", 
      "hybridization", 
      "components", 
      "labor", 
      "patterns", 
      "data", 
      "fluorescence", 
      "ratio", 
      "growth", 
      "society", 
      "cost", 
      "inside", 
      "signals", 
      "clusters", 
      "reversed polarity", 
      "polarity", 
      "American Pathologists (ASCO/CAP) HER2-testing recommendation", 
      "Pathologists (ASCO/CAP) HER2-testing recommendation", 
      "HER2-testing recommendation", 
      "intense HER2", 
      "incomplete basolateral HER2 membrane", 
      "basolateral HER2 membrane", 
      "HER2 membrane", 
      "intense basolateral membrane staining", 
      "average HER2 signals", 
      "intense-staining tumors", 
      "moderate-staining tumors", 
      "intense clear linear basolateral membrane", 
      "clear linear basolateral membrane", 
      "linear basolateral membrane", 
      "situ hybridization-testing procedure", 
      "hybridization-testing procedure"
    ], 
    "name": "Intense basolateral membrane staining indicates HER2 positivity in invasive micropapillary breast carcinoma", 
    "pagination": "1275-1286", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1124225350"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/s41379-020-0461-z"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "31974492"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/s41379-020-0461-z", 
      "https://app.dimensions.ai/details/publication/pub.1124225350"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:55", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_861.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/s41379-020-0461-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41379-020-0461-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41379-020-0461-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41379-020-0461-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41379-020-0461-z'


 

This table displays all metadata directly associated to this object as RDF triples.

343 TRIPLES      22 PREDICATES      134 URIs      117 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/s41379-020-0461-z schema:about N1199f50c669f41ebadbc33878efcb871
2 N36ec0a43386d46cab2a575cbfb5bcd07
3 N3e3b456084af4d959f31c0d31c3b8949
4 N3f6b5e514bc54ec5b97e9744a8dcced5
5 N5010de5a8af843de85368c072fd31c15
6 N5bb2ebeecd7a4de6b17f1b9591f0d91e
7 Nb42783788f0c4ed88e786ab04ff73a71
8 Nb7c65dda37de4e2fb708b7d5b5a571be
9 Nc219445a606c4d1fb275fc1d5bc561ea
10 Nd441d326aa224488b38fad4b62e7d658
11 Ne37acd17d76e4f19aea91521f7fcd251
12 anzsrc-for:11
13 anzsrc-for:1112
14 schema:author N2aedd4ce498b4095bdb2977583230a93
15 schema:citation sg:pub.10.1007/s00292-010-1278-1
16 sg:pub.10.1007/s00428-010-0952-2
17 sg:pub.10.1007/s00432-013-1409-1
18 sg:pub.10.1007/s10549-004-8235-8
19 sg:pub.10.1038/bjc.1957.43
20 sg:pub.10.1038/modpathol.2011.198
21 sg:pub.10.1038/modpathol.2017.65
22 sg:pub.10.1097/01.mp.0000052102.90815.82
23 sg:pub.10.1186/1746-1596-5-50
24 schema:datePublished 2020-01-23
25 schema:datePublishedReg 2020-01-23
26 schema:description Invasive micropapillary carcinoma is characterized by the inside-out growth of tumor clusters and displays incomplete membrane immunostaining of HER2. According to the 2018 American Society of Clinical Oncology and the College of American Pathologists (ASCO/CAP) HER2-testing recommendation, moderate to intense but incomplete staining could be scored as immunohistochemical 2+. Furthermore, the criteria of immunohistochemical 3+ for this staining pattern are not mentioned. One hundred and forty-seven cases of invasive micropapillary carcinoma with moderate-to-intense HER2 immunostaining were enrolled. Invasive micropapillary carcinoma components of all cases were scored as immunohistochemical 2+ based on the 2018 ASCO/CAP recommendation. The invasive micropapillary carcinoma component varied from 10% to 100% (mean, 80%). Invasive micropapillary carcinoma components of all 147 tumors exhibited reversed polarity and incomplete basolateral HER2 membrane staining. One hundred and seventeen of the tumors (80%, 117/147) had moderate staining, and 38 (32%, 38/117) showed HER2 gene amplification by fluorescence in-situ hybridization. HER2 gene was amplified in all the remaining 30 tumors (20%, 30/147) that exhibited intense basolateral membrane staining. Besides, average HER2 signals per cell and ratio of HER2/CEP17 were significantly higher in the intense-staining tumors compared with the moderate-staining tumors (p < 0.0001). Follow-up data were available for 140 patients. None of the patients were died. The follow-up time ranged from 1 month to 99 months (median, 57 months). Thirteen (9%, 13/140) patients exhibited disease progression (recurrence or metastasis). HER2 gene amplification was correlated inversely with estrogen receptor (p = 0.000) and progesterone receptor (p = 0.000) expression, and positively with histological grade (p = 0.003) and disease progression (p = 0.000). Invasive micropapillary carcinoma with intense clear linear basolateral membrane immunostaining indicates HER2 positivity, even if the staining is incomplete. They should be classified as immunohistochemical 3+ rather than immunohistochemical 2+, which would avoid further fluorescence in-situ hybridization-testing procedure and greatly save the related time, labor, and financial costs. Ultimately, ensure all patients with HER2 gene amplification obtain effective targeted therapy in time.
27 schema:genre article
28 schema:inLanguage en
29 schema:isAccessibleForFree false
30 schema:isPartOf N117879e6073a420a8ede709f073b333a
31 N250a5073cc354ec3a2ee99d81c131227
32 sg:journal.1098208
33 schema:keywords ASCO/CAP recommendations
34 American Pathologists (ASCO/CAP) HER2-testing recommendation
35 American Society
36 CAP recommendations
37 CEP17
38 Clinical Oncology
39 College
40 HER2
41 HER2 gene
42 HER2 gene amplification
43 HER2 membrane
44 HER2 positivity
45 HER2 signals
46 HER2-testing recommendation
47 HER2/CEP17
48 Pathologists (ASCO/CAP) HER2-testing recommendation
49 Thirteen patients
50 amplification
51 average HER2 signals
52 basolateral HER2 membrane
53 basolateral membrane
54 basolateral membrane staining
55 breast carcinoma
56 carcinoma
57 carcinoma component
58 cases
59 cells
60 clear linear basolateral membrane
61 clusters
62 components
63 cost
64 criteria
65 data
66 disease progression
67 estrogen receptor
68 expression
69 financial costs
70 fluorescence
71 further fluorescence
72 gene amplification
73 genes
74 grade
75 growth
76 histological grade
77 hybridization
78 hybridization-testing procedure
79 incomplete basolateral HER2 membrane
80 incomplete membrane
81 incomplete staining
82 inside
83 intense HER2
84 intense basolateral membrane staining
85 intense clear linear basolateral membrane
86 intense-staining tumors
87 invasive micropapillary breast carcinoma
88 invasive micropapillary carcinoma
89 invasive micropapillary carcinoma component
90 labor
91 linear basolateral membrane
92 membrane
93 membrane staining
94 micropapillary breast carcinoma
95 micropapillary carcinoma
96 micropapillary carcinoma component
97 moderate staining
98 moderate-staining tumors
99 months
100 oncology
101 patients
102 patterns
103 polarity
104 positivity
105 procedure
106 progression
107 ratio
108 receptors
109 recommendations
110 related time
111 reversed polarity
112 signals
113 situ hybridization
114 situ hybridization-testing procedure
115 society
116 staining
117 therapy
118 time
119 tumor clusters
120 tumors
121 schema:name Intense basolateral membrane staining indicates HER2 positivity in invasive micropapillary breast carcinoma
122 schema:pagination 1275-1286
123 schema:productId N0e1a88c234824e2ba94a6f52069e81ae
124 N9ff395256dc94407a4a106186c7cfac6
125 Naca8ee41fb9c4c10980e11f2c5dc55d6
126 schema:sameAs https://app.dimensions.ai/details/publication/pub.1124225350
127 https://doi.org/10.1038/s41379-020-0461-z
128 schema:sdDatePublished 2022-01-01T18:55
129 schema:sdLicense https://scigraph.springernature.com/explorer/license/
130 schema:sdPublisher Nbcdecaec31a6408a9670a8ebc1ff0141
131 schema:url https://doi.org/10.1038/s41379-020-0461-z
132 sgo:license sg:explorer/license/
133 sgo:sdDataset articles
134 rdf:type schema:ScholarlyArticle
135 N03d4d0b0cccc41e5be36cb27110f74b0 rdf:first sg:person.0731707551.36
136 rdf:rest Ncee3bd00f1ce4abb9700c1a3f0c29317
137 N0e1a88c234824e2ba94a6f52069e81ae schema:name dimensions_id
138 schema:value pub.1124225350
139 rdf:type schema:PropertyValue
140 N0eb02b2610ed4050ab4da7a04417f7d0 rdf:first sg:person.010367017310.96
141 rdf:rest Nb71ee0e5adcb4d91812653e95c7b294a
142 N117879e6073a420a8ede709f073b333a schema:volumeNumber 33
143 rdf:type schema:PublicationVolume
144 N1199f50c669f41ebadbc33878efcb871 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Middle Aged
146 rdf:type schema:DefinedTerm
147 N250a5073cc354ec3a2ee99d81c131227 schema:issueNumber 7
148 rdf:type schema:PublicationIssue
149 N2aedd4ce498b4095bdb2977583230a93 rdf:first sg:person.01106150266.94
150 rdf:rest Ne8e8967fa41648ee8335f4538050bdb7
151 N34678c7f0bbe4695b5a8acf139dc6175 rdf:first sg:person.0732213054.61
152 rdf:rest N0eb02b2610ed4050ab4da7a04417f7d0
153 N35d8a00692e747a0989ef8f0c1383b2a rdf:first sg:person.01257353151.80
154 rdf:rest N34678c7f0bbe4695b5a8acf139dc6175
155 N36ec0a43386d46cab2a575cbfb5bcd07 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Carcinoma, Ductal, Breast
157 rdf:type schema:DefinedTerm
158 N3e3b456084af4d959f31c0d31c3b8949 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Humans
160 rdf:type schema:DefinedTerm
161 N3f6b5e514bc54ec5b97e9744a8dcced5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Breast Neoplasms
163 rdf:type schema:DefinedTerm
164 N4f3efab21cba4870a8aaa15fc371e55e rdf:first sg:person.0652222332.79
165 rdf:rest N6eafa786618e45be894bb92cf63c8370
166 N5010de5a8af843de85368c072fd31c15 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Adult
168 rdf:type schema:DefinedTerm
169 N58a8206fd19f4775bfa5215970418f83 rdf:first sg:person.0703124734.33
170 rdf:rest N03d4d0b0cccc41e5be36cb27110f74b0
171 N59d4c9316fbb483d93ae8decf6baf11a rdf:first sg:person.01253773704.45
172 rdf:rest Nc1a03a59d7bd4f2086f3e5757e0dd0a1
173 N5bb2ebeecd7a4de6b17f1b9591f0d91e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Immunohistochemistry
175 rdf:type schema:DefinedTerm
176 N6eafa786618e45be894bb92cf63c8370 rdf:first sg:person.01151334034.28
177 rdf:rest Nd62744c852f64f8e89fd08a972b82e00
178 N7edcdbf1a0be4087bd19dd5c17df683e rdf:first sg:person.016051674573.23
179 rdf:rest N58a8206fd19f4775bfa5215970418f83
180 N7f5c691c9a40407991e0c94894115d00 rdf:first sg:person.01047646601.98
181 rdf:rest N59d4c9316fbb483d93ae8decf6baf11a
182 N9ff395256dc94407a4a106186c7cfac6 schema:name pubmed_id
183 schema:value 31974492
184 rdf:type schema:PropertyValue
185 Naca8ee41fb9c4c10980e11f2c5dc55d6 schema:name doi
186 schema:value 10.1038/s41379-020-0461-z
187 rdf:type schema:PropertyValue
188 Nb42783788f0c4ed88e786ab04ff73a71 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Aged
190 rdf:type schema:DefinedTerm
191 Nb71ee0e5adcb4d91812653e95c7b294a rdf:first sg:person.015065306727.60
192 rdf:rest N7edcdbf1a0be4087bd19dd5c17df683e
193 Nb7c65dda37de4e2fb708b7d5b5a571be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Biomarkers, Tumor
195 rdf:type schema:DefinedTerm
196 Nbcdecaec31a6408a9670a8ebc1ff0141 schema:name Springer Nature - SN SciGraph project
197 rdf:type schema:Organization
198 Nc1a03a59d7bd4f2086f3e5757e0dd0a1 rdf:first sg:person.01010610662.09
199 rdf:rest Ne2edcf08914542db9a42991e380c839d
200 Nc219445a606c4d1fb275fc1d5bc561ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
201 schema:name Aged, 80 and over
202 rdf:type schema:DefinedTerm
203 Ncee3bd00f1ce4abb9700c1a3f0c29317 rdf:first sg:person.01103220634.32
204 rdf:rest N4f3efab21cba4870a8aaa15fc371e55e
205 Nd441d326aa224488b38fad4b62e7d658 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
206 schema:name Female
207 rdf:type schema:DefinedTerm
208 Nd62744c852f64f8e89fd08a972b82e00 rdf:first sg:person.0635011534.17
209 rdf:rest N7f5c691c9a40407991e0c94894115d00
210 Ne2edcf08914542db9a42991e380c839d rdf:first sg:person.01333675634.21
211 rdf:rest rdf:nil
212 Ne37acd17d76e4f19aea91521f7fcd251 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
213 schema:name Receptor, ErbB-2
214 rdf:type schema:DefinedTerm
215 Ne8e8967fa41648ee8335f4538050bdb7 rdf:first sg:person.01000326254.30
216 rdf:rest N35d8a00692e747a0989ef8f0c1383b2a
217 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
218 schema:name Medical and Health Sciences
219 rdf:type schema:DefinedTerm
220 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
221 schema:name Oncology and Carcinogenesis
222 rdf:type schema:DefinedTerm
223 sg:journal.1098208 schema:issn 0893-3952
224 1530-0285
225 schema:name Modern Pathology
226 schema:publisher Springer Nature
227 rdf:type schema:Periodical
228 sg:person.01000326254.30 schema:affiliation grid-institutes:grid.11841.3d
229 schema:familyName Yang
230 schema:givenName Fei
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01000326254.30
232 rdf:type schema:Person
233 sg:person.01010610662.09 schema:affiliation grid-institutes:grid.11841.3d
234 schema:familyName Zhou
235 schema:givenName Xiaoyan
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01010610662.09
237 rdf:type schema:Person
238 sg:person.010367017310.96 schema:affiliation grid-institutes:grid.11841.3d
239 schema:familyName Li
240 schema:givenName Ming
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010367017310.96
242 rdf:type schema:Person
243 sg:person.01047646601.98 schema:affiliation grid-institutes:grid.11841.3d
244 schema:familyName Tang
245 schema:givenName Shaoxian
246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047646601.98
247 rdf:type schema:Person
248 sg:person.01103220634.32 schema:affiliation grid-institutes:grid.11841.3d
249 schema:familyName Bi
250 schema:givenName Rui
251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103220634.32
252 rdf:type schema:Person
253 sg:person.01106150266.94 schema:affiliation grid-institutes:grid.11841.3d
254 schema:familyName Zhou
255 schema:givenName Shuling
256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106150266.94
257 rdf:type schema:Person
258 sg:person.01151334034.28 schema:affiliation grid-institutes:grid.11841.3d
259 schema:familyName Cheng
260 schema:givenName Yufan
261 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01151334034.28
262 rdf:type schema:Person
263 sg:person.01253773704.45 schema:affiliation grid-institutes:grid.11841.3d
264 schema:familyName Sun
265 schema:givenName Xiangjie
266 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01253773704.45
267 rdf:type schema:Person
268 sg:person.01257353151.80 schema:affiliation grid-institutes:grid.11841.3d
269 schema:familyName Bai
270 schema:givenName Qianming
271 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257353151.80
272 rdf:type schema:Person
273 sg:person.01333675634.21 schema:affiliation grid-institutes:grid.11841.3d
274 schema:familyName Yang
275 schema:givenName Wentao
276 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333675634.21
277 rdf:type schema:Person
278 sg:person.015065306727.60 schema:affiliation grid-institutes:grid.11841.3d
279 schema:familyName Zhong
280 schema:givenName Siyuan
281 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015065306727.60
282 rdf:type schema:Person
283 sg:person.016051674573.23 schema:affiliation grid-institutes:grid.11841.3d
284 schema:familyName Lv
285 schema:givenName Hong
286 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016051674573.23
287 rdf:type schema:Person
288 sg:person.0635011534.17 schema:affiliation grid-institutes:grid.11841.3d
289 schema:familyName Yu
290 schema:givenName Baohua
291 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635011534.17
292 rdf:type schema:Person
293 sg:person.0652222332.79 schema:affiliation grid-institutes:grid.11841.3d
294 schema:familyName Xu
295 schema:givenName Xiaoli
296 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652222332.79
297 rdf:type schema:Person
298 sg:person.0703124734.33 schema:affiliation grid-institutes:grid.11841.3d
299 schema:familyName Shui
300 schema:givenName Ruohong
301 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703124734.33
302 rdf:type schema:Person
303 sg:person.0731707551.36 schema:affiliation grid-institutes:grid.11841.3d
304 schema:familyName Tu
305 schema:givenName Xiaoyu
306 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731707551.36
307 rdf:type schema:Person
308 sg:person.0732213054.61 schema:affiliation grid-institutes:grid.11841.3d
309 schema:familyName Li
310 schema:givenName Anqi
311 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0732213054.61
312 rdf:type schema:Person
313 sg:pub.10.1007/s00292-010-1278-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044174834
314 https://doi.org/10.1007/s00292-010-1278-1
315 rdf:type schema:CreativeWork
316 sg:pub.10.1007/s00428-010-0952-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008262506
317 https://doi.org/10.1007/s00428-010-0952-2
318 rdf:type schema:CreativeWork
319 sg:pub.10.1007/s00432-013-1409-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040283919
320 https://doi.org/10.1007/s00432-013-1409-1
321 rdf:type schema:CreativeWork
322 sg:pub.10.1007/s10549-004-8235-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033707946
323 https://doi.org/10.1007/s10549-004-8235-8
324 rdf:type schema:CreativeWork
325 sg:pub.10.1038/bjc.1957.43 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033483945
326 https://doi.org/10.1038/bjc.1957.43
327 rdf:type schema:CreativeWork
328 sg:pub.10.1038/modpathol.2011.198 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027273989
329 https://doi.org/10.1038/modpathol.2011.198
330 rdf:type schema:CreativeWork
331 sg:pub.10.1038/modpathol.2017.65 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090916693
332 https://doi.org/10.1038/modpathol.2017.65
333 rdf:type schema:CreativeWork
334 sg:pub.10.1097/01.mp.0000052102.90815.82 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043809974
335 https://doi.org/10.1097/01.mp.0000052102.90815.82
336 rdf:type schema:CreativeWork
337 sg:pub.10.1186/1746-1596-5-50 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078194351
338 https://doi.org/10.1186/1746-1596-5-50
339 rdf:type schema:CreativeWork
340 grid-institutes:grid.11841.3d schema:alternateName Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong’an Road, 200032, Shanghai, PR China
341 schema:name Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong’an Road, 200032, Shanghai, PR China
342 Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong’an Road, 200032, Shanghai, PR China
343 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...